Produced by Knowable Magazine with HunniMedia

Scott Thompson (University of Maryland, School of Medicine) discusses the current evidence for ketamine as a psychiatric treatment for severe depression, the unknown risks of long-term use and both the promises and risks of the newly approved esketamine nasal spray.

To learn more, check out our article, “Listening to ketamine.”